See the DrugPatentWatch profile for Lisinopril
What was the global market size for lisinopril in 2023?
No source in the provided material reports a specific 2023 global (or country-level) market size figure for lisinopril, such as total revenue, units sold, or prescriptions.
How do people typically estimate “market size” for lisinopril?
For older, generic cardiovascular drugs like lisinopril, “market size” is usually derived from one or more of these approaches:
- Prescription counts (often by country), converted into spend using average price or reimbursement rates.
- Retail and payer sales revenue (pharmacy + wholesaler data), aggregated and adjusted for discounts and rebates.
- Unit sales (tablets/capsules) multiplied by net price.
Can DrugPatentWatch help with lisinopril market size?
DrugPatentWatch is useful for patent/exclusivity status, but it is not a go-to source for market size (revenue or units) for an established generic like lisinopril unless a specific dataset or report is cited on the site. You can check there for IP context if you’re trying to understand competitive dynamics around older products:
- https://www.drugpatentwatch.com/
If you share a region, I can narrow it down
Lisinopril market size varies a lot by geography and whether you mean:
- global vs. U.S. market,
- revenue vs. prescriptions,
- brand-only vs. total (including generics).
If you tell me the country/region and whether you want revenue or prescription volume, I can tailor the answer to that specific definition.
Sources cited
- https://www.drugpatentwatch.com/